as on March 7, 2026 at 7:59 am IST
Day's Low
Day's High
2.28%
Downside
1.95%
Upside
52 Week's Low
52 Week's High
65.80%
Downside
59.28%
Upside
Check Aclaris Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$335.9M
EPS (TTM)
-0.596
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.42
Industry PE ratio
-3.1180442804428044
PEG Ratio
-0.13
EBITDA
-74.0M
Revenue (TTM)
7.8M
Profit Margin
0.00%
Return On Equity TTM
-50.20%
Track how Aclaris Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aclaris Therapeutics Inc in the last 5 years
Lowest (-15.56x)
June 30, 2021
Industry (-3.12x)
March 6, 2026
Today (-1.42x)
March 6, 2026
Highest (-0.99x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.42x
Compare market cap, revenue, PE, and other key metrics of Aclaris Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $335.9M | -85.36% | -1.42 | 0.00% | |
| BUY | $43.4B | 123.52% | 141.08 | 8.45% | |
| BUY | $121.4B | 117.39% | 31.15 | 32.94% | |
| NA | $33.1B | NA | 586.31 | 5.37% | |
| BUY | $83.3B | 65.72% | 18.98 | 31.41% |
The Aclaris Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aclaris Therapeutics Inc investment value today
Current value as on today
₹1,74,046
Returns
₹74,046
(+74.05%)
Returns from Aclaris Therapeutics Inc Stock
₹68,681 (+68.68%)
Dollar Returns*
₹5,365 (+5.36%)
Based on 15 analysts
40.00%
Buy
60.00%
Hold
0.00%
Sell
Based on 15 analysts, 60% of analysts recommend a 'HOLD' rating for Aclaris Therapeutics Inc. Average target price of $8.29
Get share price movements and forecasts by analysts on Aclaris Therapeutics Inc.
What analysts predicted
62.97%UPSIDE
Target Price
$8.29
Current Price
$3.07
Analyzed by
15 Analysts
Target
$8.29
Aclaris Therapeutics Inc target price $8.29, a slight upside of 62.97% compared to current price of $3.07. According to 15 analysts rating.
Search interest for Aclaris Therapeutics Inc Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, ACRS has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 7 days, ACRS stock has moved up by 8.7%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 64.9% return, outperforming this stock by 122.8%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -14.61M → -19.79M (in $), with an average decrease of 35.5% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 3.29M → 1.29M (in $), with an average decrease of 60.8% per quarter
| Organisation | Aclaris Therapeutics Inc |
| Headquarters | 701 Lee Road, Wayne, PA, United States, 19087 |
| Industry | Health Technology |
| CEO | Dr. Neal S. Walker D.O., M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
Dr. Hugh M. Davis Ph.D. | President, COO & Director |
Mr. Kevin Balthaser | Chief Financial Officer |
Mr. Shaun Selness Ph.D. | Senior VP, Head of Discovery & Preclinical Sciences |
Mr. Steve Tucker | Executive Vice President of Project Leadership |
Mr. Ajay Aggarwal M.B.A., M.D. | Senior Vice President of Clinical Development |
Dr. Jesse W. Hall M.D. | Chief Medical Officer |
Ms. Nina Samra M.S. | Senior Vice President of Clinical Operations |
Ms. Meghan Dunsmore | Senior Vice President of Finance |
Aclaris Therapeutics Inc share price today is $3.07 as on at the close of the market. Aclaris Therapeutics Inc share today touched a day high of $3.13 and a low of $3.
Aclaris Therapeutics Inc share touched a 52 week high of $4.89 on and a 52 week low of $1.05 on . Aclaris Therapeutics Inc stock price today i.e. is closed at $3.07,which is 37.22% down from its 52 week high and 192.38% up from its 52 week low.
Aclaris Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Aclaris Therapeutics Inc (ACRS) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Aclaris Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aclaris Therapeutics Inc share’s latest price of $3.07 as on March 7, 2026 at 2:29 am IST, you will get 3.2573 shares of Aclaris Therapeutics Inc. Learn more about
fractional shares .
Aclaris Therapeutics Inc stock has given -85.36% share price returns and 25.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?